The effects of direct-acting antiviral agents on the frequency of myeloid-derived suppressor cells and natural killer cells in patients with chronic hepatitis C

Journal of Medical Virology
Yi-Ting LiChao-Shuang Lin

Abstract

Currently, hepatitis C antiviral therapy is entering a new era with the use of direct-acting antiviral (DAA) agents. However, the precise immunological influences of DAA therapy in patients with chronic hepatitis C (CHC) are insufficiently understood. This study aimed to investigate the effects of DAA therapy on the frequency of myeloid-derived suppressor cells (MDSCs), T lymphocytes, and natural killer (NK) cells in patients with CHC. Thirty-two treatment-naive CHC patients were treated with DAA therapy, and the frequency of immune cells was analyzed by flow cytometry at various time points during and after therapy. Sixteen healthy donors were recruited for comparison. DAA therapy decreased the frequency of MDSCs and monocytic MDSCs in patients with CHC to a normal level. DAA therapy also increased the CD8+ T and NK cell levels in patients with CHC. In addition, activation (NKp30 and NKp46) and inhibitory (NKG2A) receptors on NK cells were downregulated to yield an NK cell phenotype resembling that observed in the healthy controls. This study provides insight into the normalization of immune cell levels under DAA therapy and indicates that restoration of the immune system in patients with CHC strongly supports long-term curati...Continue Reading

References

Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Aug 19, 2005·Nature·David G Bowen, Christopher M Walker
Feb 7, 2009·Nature Reviews. Immunology·Dmitry I Gabrilovich, Srinivas Nagaraj
Jul 10, 2009·The Journal of Clinical Investigation·Barbara Rehermann
Feb 10, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Srinivas NagarajDmitry I Gabrilovich
Dec 24, 2010·Virulence·Johan K SandbergVeronica D Gonzalez
Mar 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hong-Shiue ChouShiguang Qian
Sep 29, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Robert S TackeYoung S Hahn
Oct 11, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Lucy Golden-MasonUNKNOWN Virahep-C Study Group
Jan 14, 2012·PLoS Pathogens·Raymond M WelshStina L Urban
Mar 23, 2012·Nature Reviews. Immunology·Dmitry I GabrilovichVincenzo Bronte
Jun 7, 2014·Journal of Hepatology·Bianca MartinRobert Thimme
Jul 2, 2014·The Journal of Clinical Investigation·Eric G MeissnerShyamasundaran Kottilil
Oct 16, 2014·European Journal of Immunology·Rik A de GroenAndré Boonstra
Apr 8, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K Rajender ReddyNezam Afdhal
Jun 23, 2015·Immunology·Stefania MantovaniMario U Mondelli
May 10, 2017·Journal of Medical Virology·Premashis KarVijay Kumar Karra
Aug 29, 2017·Antiviral Research·Meike H van der ReeHendrik W Reesink
Apr 29, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hawwa AlaoMarc G Ghany

❮ Previous
Next ❯

Citations

Dec 25, 2019·Cold Spring Harbor Perspectives in Medicine·Hugo R Rosen, Lucy Golden-Mason
Nov 3, 2020·Frontiers in Immunology·Heiner WedemeyerNiklas K Björkström

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.